The Raise
Aurenar, a St. Louis-based neurotechnology startup spun out of Washington University, closed an oversubscribed $5.7 million seed round in July 2026.
What They're Building
V-Link is a non-invasive, single-use, wireless ear-worn device that delivers transauricular vagus nerve stimulation (taVNS).
FDA Status
In June 2026, the FDA granted Breakthrough Device Designation to the V-Link system.
Why This Matters for Body-Mind Practice
This is vagus nerve stimulation moving from wellness into critical care.
